29 related articles for article (PubMed ID: 9485038)
1. Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.
Demir S; Razizadeh N; Indersie E; Branchereau S; Cairo S; Kappler R
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285887
[TBL] [Abstract][Full Text] [Related]
2. Collapse of Intra-Tumor Cooperation Induced by Engineered Defector Cells.
Archetti M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359576
[TBL] [Abstract][Full Text] [Related]
3. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children.
Visani M; Marucci G; Biase D; Giangaspero F; Buttarelli FR; Brandes AA; Franceschi E; Acquaviva G; Ciarrocchi A; Rhoden KJ; Tallini G; Pession A
Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32365560
[TBL] [Abstract][Full Text] [Related]
4. Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?
Demirci NS; Dogan M; Erdem GU; Kacar S; Turhan T; Kilickap S; Cigirgan LC; Kayacetin E; Bozkaya Y; Zengin N
Saudi J Gastroenterol; 2017; 23(3):183-189. PubMed ID: 28611342
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
Chatterjee M; Ben-Josef E; Thomas DG; Morgan MA; Zalupski MM; Khan G; Andrew Robinson C; Griffith KA; Chen CS; Ludwig T; Bekaii-Saab T; Chakravarti A; Williams TM
Sci Rep; 2015 Jun; 5():10867. PubMed ID: 26065715
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer.
Archetti M; Ferraro DA; Christofori G
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1833-8. PubMed ID: 25624490
[TBL] [Abstract][Full Text] [Related]
7. Igf1r signaling is indispensable for preimplantation development and is activated via a novel function of E-cadherin.
Bedzhov I; Liszewska E; Kanzler B; Stemmler MP
PLoS Genet; 2012; 8(3):e1002609. PubMed ID: 22479204
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.
Schaeffer DF; Owen DR; Lim HJ; Buczkowski AK; Chung SW; Scudamore CH; Huntsman DG; Ng SS; Owen DA
BMC Cancer; 2010 Feb; 10():59. PubMed ID: 20178612
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.
Csernus VJ; Schally AV; Kiaris H; Armatis P
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3098-103. PubMed ID: 10077643
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
11. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
12. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.
Lamm GM; Christofori G
Cancer Res; 1998 Feb; 58(4):801-7. PubMed ID: 9485038
[TBL] [Abstract][Full Text] [Related]
13. An insulin-like growth factor-mediated, phosphatidylinositol 3' kinase-independent survival signaling pathway in beta tumor cells.
Burtscher I; Compagni A; Lamm GM; Christofori G
Cancer Res; 1999 Aug; 59(16):3923-6. PubMed ID: 10463584
[TBL] [Abstract][Full Text] [Related]
14. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
Christofori G; Naik P; Hanahan D
Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
[TBL] [Abstract][Full Text] [Related]
15. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
Alexia C; Lasfer M; Groyer A
Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
